Latest News in the pharma Industry

Research & Development

FDA Extends Action Date for sBLA Application for Opdivo in Previously Untreated Advanced Melanoma

FDA Extends Action Date for sBLA Application for Opdivo in Previously Untreated Advanced Melanoma

13 Aug 2015

Read more 
Pivotal Phase II Study of Investigational Medicine Venetoclax Met Primary Endpoint in a Hard-to-Treat Type of Chronic Lymphocytic Leukemia

Pivotal Phase II Study of Investigational Medicine Venetoclax Met Primary Endpoint in a Hard-to-Treat Type of Chronic Lymphocytic Leukemia

13 Aug 2015

Read more 
Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumours

Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumours

13 Aug 2015

Read more 
Eleven Biotherapeutics - First Patients Dosed with EBI-005 in Phase III Study in Patients with Moderate to Severe Allergic Conjunctivitis

Eleven Biotherapeutics - First Patients Dosed with EBI-005 in Phase III Study in Patients with Moderate to Severe Allergic Conjunctivitis

12 Aug 2015

Read more 
Boehringer Ingelheim and Circuit Therapeutics Announce New Collaboration to Discover Novel Medicines for Obesity

Boehringer Ingelheim and Circuit Therapeutics Announce New Collaboration to Discover Novel Medicines for Obesity

12 Aug 2015

Read more 
FDA Accepts a sNDA for Review of Brintellix (Vortioxetine) Trial Data that Assessed Cognitive Function in Patients with MDD

FDA Accepts a sNDA for Review of Brintellix (Vortioxetine) Trial Data that Assessed Cognitive Function in Patients with MDD

12 Aug 2015

Read more 
DefiniGEN Licenses Lung Stem Cell Technology from University of Cambridge

DefiniGEN Licenses Lung Stem Cell Technology from University of Cambridge

11 Aug 2015

Read more 
Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate Published in Haemophilia

Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate Published in Haemophilia

11 Aug 2015

Read more 
Orexigen and Takeda Announce an Amended and Restated Collaboration Agreement

Orexigen and Takeda Announce an Amended and Restated Collaboration Agreement

7 Aug 2015

Read more 
Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study

Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study

5 Aug 2015

Read more 
BMS Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the US

BMS Establishes Collaborative Immuno-Oncology Rare Population Malignancy (I-O RPM) Program in the US

5 Aug 2015

Read more 
First US Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI and RE-CIRCUIT Trials Evaluating Pradaxa

First US Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI and RE-CIRCUIT Trials Evaluating Pradaxa

31 Jul 2015

Read more